Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Discovery Value Fund

Q2 2023 · 13F-HR

Discovery Value Fundholdings as filed

Filed 2023-08-11 · accession 0001750451-23-000005

$197.2M
Reported value
6
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
25809K105DASHDOORDASH INC$126.0M63.9%1,648,516CommonSOLE
46090E103QQQINVESCO QQQ TR$26.4M13.4%71,488CommonSOLE
45826J105NTLAINTELLIA THERAPEUTICS INC$22.9M11.6%561,561CommonSOLE
81141R100SESEA LTD$15.9M8.05%273,620CommonSOLE
037833100AAPLAPPLE INC$3.1M1.57%15,998CommonSOLE
87918A105TDOCTELADOC HEALTH INC$2.9M1.46%113,998CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.